Literature DB >> 20214878

Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.

Yi Ting1, Daniel J Medina, Roger K Strair, Dale G Schaar.   

Abstract

Differentiation agents such as 12-O-tetradecanoylphorbol-13-acetate (TPA) engage cell signaling pathways that activate downstream transcriptional programs necessary for cell differentiation. Recent evidence has indicated microRNAs (miRNAs) are an integral part of these transcriptional programs, which target key proteins and impact cell growth thereby facilitating changes required for differentiation. To further investigate the role of miRNAs in cell growth and differentiation, we focused on miR-22, a miRNA induced by TPA in the HL-60 leukemia cell line model of monocytic differentiation. TPA-induced miR-22 transcription was found to be downstream of the protein kinase c (PKC)-extracellular regulated kinase (ERK) signaling module, a pathway central to the growth and differentiation of many different cell types. Enforced miR-22 expression inhibited the growth of several different cancer cell lines, causing an accumulation of cells in the G1 phase of the cell cycle. The mechanism of miR-22's inhibitory effects involves targeting of the obligate c-Myc binding partner Max. Enforced miR-22 expression presumably lowers Max levels available for Myc binding, which differentially influenced the transcription of downstream targets of the Myc-Max complex. Our study provides additional support for miRNAs targeting key cellular regulatory microcircuits such as those governed by the Myc-Max transcriptional complex as well as their being active participants in cell growth and differentiation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214878     DOI: 10.1016/j.bbrc.2010.03.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  MicroRNA expression in maturing murine megakaryocytes.

Authors:  Joanna B Opalinska; Alexey Bersenev; Zhe Zhang; Alec A Schmaier; John Choi; Yu Yao; Janine D'Souza; Wei Tong; Mitchell J Weiss
Journal:  Blood       Date:  2010-08-18       Impact factor: 22.113

2.  Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.

Authors:  Andrea Hoffmann; Yusen Huang; Rinako Suetsugu-Maki; Carol S Ringelberg; Craig R Tomlinson; Katia Del Rio-Tsonis; Panagiotis A Tsonis
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

3.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

4.  Effects of simulated microgravity on expression profile of microRNA in human lymphoblastoid cells.

Authors:  Lingegowda S Mangala; Ye Zhang; Zhenhua He; Kamal Emami; Govindarajan T Ramesh; Michael Story; Larry H Rohde; Honglu Wu
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

Review 5.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

6.  miR-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor Sp1.

Authors:  Mei-Mei Guo; Li-Hua Hu; Yong-Qiang Wang; Peng Chen; Jian-Guo Huang; Ning Lu; Jiang-Hong He; Cheng-Gong Liao
Journal:  Med Oncol       Date:  2013-03-26       Impact factor: 3.064

7.  microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Authors:  J Zhang; Y Yang; T Yang; Y Liu; A Li; S Fu; M Wu; Z Pan; W Zhou
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

8.  Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.

Authors:  Ganepola Ap Ganepola; John R Rutledge; Paritosh Suman; Anusak Yiengpruksawan; David H Chang
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

9.  MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.

Authors:  Jordi Berenguer; Antonio Herrera; Laura Vuolo; Blanca Torroba; Franc Llorens; Lauro Sumoy; Sebastian Pons
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

10.  The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.

Authors:  J K Parrish; M Sechler; R A Winn; P Jedlicka
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.